Cibc Private Wealth Group, LLC Adamis Pharmaceuticals Corp Transaction History

Cibc Private Wealth Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 16, 2019	SELL	$0.7 - $1.46 $10,500 - $21,900	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.25 - $4.8 $9,000 - $19,200	4,000 Added 36.36%	15,000 $53,000
Q2 2018 Aug 02, 2018	BUY	$3.2 - $4.7 $16,000 - $23,500	5,000 Added 83.33%	11,000 $35,000
Q1 2018 May 17, 2018	SELL	$2.55 - $4.85 $7,649 - $14,549	-3,000 Reduced 33.33%	6,000 $21,000
Q4 2017 Feb 12, 2018	BUY	$3.5 - $5.65 $31,500 - $50,850	9,000	9,000 $40,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.